Euclidean Capital »

Rapt Therapeutics shares owned by Euclidean Capital

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Euclidean Capital from 13F filings

Historical chart of Euclidean Capital investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Euclidean Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 82k 25.79
2025-06-30 $658k 82k 8.00